Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Aplastic Anemia and Other Marrow Failure Syndrome Clinical Trial

Official title:

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01310959
• Other study ID #: RAC# 2021-084
• Secondary ID: RAC# 2021-084
• Status: Recruiting
• Phase: N/A
• First received: March 6, 2011
• Last updated: December 11, 2011
• Start date: January 2003

Study information

• Verified date: December 2011
• Source: King Faisal Specialist Hospital & Research Center
• Contact: H Al-Zahrani, M.D.
• Phone: +966-1-4423949
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Description:

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 88
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 14 Years to 85 Years

Eligibility

Inclusion Criteria:

• Patients with diagnosed Aplastic Anemia and Other Marrow Failure Syndrome Database.

Exclusion Criteria:

• Patients with diagnosis other than Aplastic Anemia and Other Marrow Failure Syndrome Database.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Anemia
• Anemia, Aplastic
• Aplastic Anemia and Other Marrow Failure Syndrome
• Syndrome

Intervention

Other:
• Database
Database

Locations

Country	Name	City	State
Saudi Arabia	Kfsh & Rc	Riyadh

Sponsors (1)

Lead Sponsor	Collaborator
King Faisal Specialist Hospital & Research Center

Country where clinical trial is conducted

Saudi Arabia,